Philochem is a daughter company of Philogen focused on the development of armed antibodies, DNA-encoded libraries and ligands for cancer imaging. The company owns a proprietary platform ESAC (Encoded Self-Assembling Chemical) which enables to construct DEL libraries of unprecedented size.